Literature DB >> 8815899

Consequences of trisomy 16 for mouse brain development: corticogenesis in a model of Down syndrome.

T F Haydar1, M E Blue, M E Molliver, B K Krueger, P J Yarowsky.   

Abstract

We have studied abnormalities in the tangential and radial expansion of the cerebral cortex during fetal development in the trisomy 16 (Ts16) mouse, a model for human trisomy 21 (Down syndrome). Slowed tangential expansion of the neuroepithelium in Ts16 resulted in a reduction of final telencephalic size and is predicted to decrease the number of radial cortical units in the mature brain. In addition, radial growth of the Ts16 cortex was delayed at the time of peak cortical neurogenesis in normal mice, but by embryonic day 18 the cortex reached normal thickness. Because mouse chromosome 16 shares many genes with human chromosome 21, abnormalities in Ts16 brain development may parallel abnormalities in trisomy 21.

Entities:  

Mesh:

Year:  1996        PMID: 8815899      PMCID: PMC6579184     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

1.  Growth and targeting of subplate axons and establishment of major cortical pathways.

Authors:  J A De Carlos; D D O'Leary
Journal:  J Neurosci       Date:  1992-04       Impact factor: 6.167

2.  Studies on Down's syndrome in tissue culture. I. Growth rates and protein contents of fibroblast cultures.

Authors:  D J Segal; E E McCoy
Journal:  J Cell Physiol       Date:  1974-02       Impact factor: 6.384

Review 3.  Numbers, time and neocortical neuronogenesis: a general developmental and evolutionary model.

Authors:  V S Caviness; T Takahashi; R S Nowakowski
Journal:  Trends Neurosci       Date:  1995-09       Impact factor: 13.837

4.  Mode of cell proliferation in the developing mouse neocortex.

Authors:  T Takahashi; R S Nowakowski; V S Caviness
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

5.  Tangential organization of thalamic projections to the neocortex in the mouse.

Authors:  V S Caviness; D O Frost
Journal:  J Comp Neurol       Date:  1980-11-15       Impact factor: 3.215

6.  Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months.

Authors:  B Schmidt-Sidor; K E Wisniewski; T H Shepard; E A Sersen
Journal:  Clin Neuropathol       Date:  1990 Jul-Aug       Impact factor: 1.368

7.  Cultured hippocampal neurons from trisomy 16 mouse, a model for Down's syndrome, have an abnormal action potential due to a reduced inward sodium current.

Authors:  Z Galdzicki; E Coan; S I Rapoport
Journal:  Brain Res       Date:  1993-02-26       Impact factor: 3.252

8.  Glutamate as a hippocampal neuron survival factor: an inherited defect in the trisomy 16 mouse.

Authors:  L L Bambrick; P J Yarowsky; B K Krueger
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

Review 9.  Genetic basis for a mouse model of Down syndrome.

Authors:  R H Reeves; J D Gearhart; J W Littlefield
Journal:  Brain Res Bull       Date:  1986-06       Impact factor: 4.077

10.  Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex.

Authors:  A J Blaschke; K Staley; J Chun
Journal:  Development       Date:  1996-04       Impact factor: 6.868

View more
  12 in total

Review 1.  Trisomy 21 and early brain development.

Authors:  Tarik F Haydar; Roger H Reeves
Journal:  Trends Neurosci       Date:  2011-12-09       Impact factor: 13.837

Review 2.  Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.

Authors:  Eric D Hamlett; Heather A Boger; Aurélie Ledreux; Christy M Kelley; Elliott J Mufson; Maria F Falangola; David N Guilfoyle; Ralph A Nixon; David Patterson; Nathan Duval; Ann-Charlotte E Granholm
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

Review 3.  Advanced microscopic imaging methods to investigate cortical development and the etiology of mental retardation.

Authors:  Tarik F Haydar
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2005

4.  Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome.

Authors:  Joseph W Goodliffe; Jose Luis Olmos-Serrano; Nadine M Aziz; Jeroen L A Pennings; Faycal Guedj; Diana W Bianchi; Tarik F Haydar
Journal:  J Neurosci       Date:  2016-03-09       Impact factor: 6.167

Review 5.  Human Models Are Needed for Studying Human Neurodevelopmental Disorders.

Authors:  Xinyu Zhao; Anita Bhattacharyya
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

6.  Role of founder cell deficit and delayed neuronogenesis in microencephaly of the trisomy 16 mouse.

Authors:  T F Haydar; R S Nowakowski; P J Yarowsky; B K Krueger
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

7.  Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome.

Authors:  Chelsee A Hewitt; King-Hwa Ling; Tobias D Merson; Ken M Simpson; Matthew E Ritchie; Sarah L King; Melanie A Pritchard; Gordon K Smyth; Tim Thomas; Hamish S Scott; Anne K Voss
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

8.  Restrained Phosphatidylcholine Synthesis in a Cellular Model of Down's Syndrome is Associated with the Overexpression of Dyrk1A.

Authors:  Maruan Hijazi; José M Medina; Ana Velasco
Journal:  Mol Neurobiol       Date:  2016-01-23       Impact factor: 5.590

9.  Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome.

Authors:  Nadine M Aziz; Faycal Guedj; Jeroen L A Pennings; Jose Luis Olmos-Serrano; Ashley Siegel; Tarik F Haydar; Diana W Bianchi
Journal:  Dis Model Mech       Date:  2018-06-12       Impact factor: 5.758

10.  Down Syndrome Cognitive Phenotypes Modeled in Mice Trisomic for All HSA 21 Homologues.

Authors:  Pavel V Belichenko; Alexander M Kleschevnikov; Ann Becker; Grant E Wagner; Larisa V Lysenko; Y Eugene Yu; William C Mobley
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.